| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1068965665 |
| P356 | DOI | 10.2119/MOLMED.2014.00059 |
| P932 | PMC publication ID | 4212010 |
| P698 | PubMed publication ID | 25105301 |
| P2093 | author name string | Fang Wang | |
| Li-wu Fu | |||
| Xiao-kun Wang | |||
| Zhen-cong Huang | |||
| Yi-fan Chen | |||
| Shao-lin Ma | |||
| Ya-peng Hu | |||
| P2860 | cites work | Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line | Q24338329 |
| Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases | Q24601963 | ||
| Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters | Q24617999 | ||
| Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding | Q24657908 | ||
| Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase | Q24672837 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| The protein kinase family: conserved features and deduced phylogeny of the catalytic domains | Q27860528 | ||
| Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function | Q28475378 | ||
| Major vault protein LRP-related multidrug resistance | Q29031989 | ||
| Targeting multidrug resistance in cancer | Q29616803 | ||
| The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux | Q32046906 | ||
| A family of drug transporters: the multidrug resistance-associated proteins. | Q34004952 | ||
| Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1. | Q34135435 | ||
| Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate | Q34219593 | ||
| The Role of ABC Transporters in Clinical Practice | Q34268081 | ||
| Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. | Q53373657 | ||
| Non-P-glycoprotein-mediated multidrug-resistant human KB cells selected in medium containing adriamycin, cepharanthine, and mezerein. | Q54196458 | ||
| Expression of a multidrug resistance gene in human cancers | Q69366790 | ||
| Lung resistance-related protein: determining its role in multidrug resistance | Q73053901 | ||
| Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines | Q73899281 | ||
| Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells | Q73941067 | ||
| Human metabolism of lapatinib, a dual kinase inhibitor: implications for hepatotoxicity | Q85030737 | ||
| Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. | Q34369690 | ||
| Association of Lyn tyrosine kinase with the nuclear matrix and cell-cycle-dependent changes in matrix-associated tyrosine kinase activity | Q34376815 | ||
| Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival | Q34508553 | ||
| Plant ATP-binding cassette transporters | Q34607674 | ||
| Mammalian ABC transporters in health and disease | Q34667449 | ||
| Metabolic intermediate complex formation of human cytochrome P450 3A4 by lapatinib | Q35002433 | ||
| Epidermal growth factor receptor (EGFR) signaling in cancer | Q36353031 | ||
| Mechanisms and strategies to overcome multiple drug resistance in cancer | Q36404538 | ||
| Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins | Q36525551 | ||
| Transport of glutathione and glutathione conjugates by MRP1. | Q36527103 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system | Q36610461 | ||
| Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. | Q36899379 | ||
| Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 | Q37119716 | ||
| A single-arm phase II trial of first-line paclitaxel in combination with lapatinib in HER2-overexpressing metastatic breast cancer | Q37810735 | ||
| Assessment of cytochrome p450 enzyme inhibition and inactivation in drug discovery and development | Q37841644 | ||
| ABC transporters and their role in nucleoside and nucleotide drug resistance | Q37979617 | ||
| ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance | Q38510908 | ||
| Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells. | Q38618124 | ||
| Nilotinib enhances the efficacy of conventional chemotherapeutic drugs in CD34⁺CD38⁻ stem cells and ABC transporter overexpressing leukemia cells | Q39013427 | ||
| Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance | Q39805970 | ||
| Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol | Q40036920 | ||
| Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance | Q40050525 | ||
| Involvement of CD147 in regulation of multidrug resistance to P-gp substrate drugs and in vitro invasion in breast cancer cells | Q40144190 | ||
| Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo | Q40345597 | ||
| Gefitinib, an EGFR tyrosine kinase inhibitor, directly inhibits the function of P-glycoprotein in multidrug resistant cancer cells. | Q40410062 | ||
| Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. | Q40530013 | ||
| Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material | Q40633176 | ||
| Resistant mechanisms of anthracyclines--pirarubicin might partly break through the P-glycoprotein-mediated drug-resistance of human breast cancer tissues | Q40757148 | ||
| A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells | Q41073847 | ||
| Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells | Q42833544 | ||
| HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. | Q44450066 | ||
| Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance | Q44687014 | ||
| Expression of lung resistance-related protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia | Q44799762 | ||
| Screening novel, potent multidrug-resistant modulators from imidazole derivatives | Q45011364 | ||
| Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells | Q47968983 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 390-399 | |
| P577 | publication date | 2014-09-08 | |
| P1433 | published in | Molecular Medicine | Q6895961 |
| P1476 | title | Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function | |
| P478 | volume | 20 |
| Q37739472 | Alectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivo |
| Q33596508 | Detection approaches for multidrug resistance genes of leukemia |
| Q36186203 | Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice |
| Q52651567 | Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway. |
| Q36232153 | Lapatinib promotes the incidence of hepatotoxicity by increasing chemotherapeutic agent accumulation in hepatocytes |
| Q38743568 | Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts |
| Q57816977 | Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells |
| Q49888021 | Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells. |
Search more.